Editorial: which inflammatory bowel disease patients should be screened for Epstein‐Barr virus infection? Authors’ reply

Introduction Lymphoma is a dreaded complication of inflammatory bowel diseases (IBD). Knowledge about lymphoma in patients with IBD is limited to epidemiological data and risk factors description. We performed a systematic review to describe clinical characteristics and prognosis of lymphoma in patients with IBD. Methods Electronic databases were searched up to 1 st June 2020. All published clinical characteristics of lymphoma occurring in patients with IBD were collected. Results Eleven studies were included. A total of 589 lymphomas were described in patients with IBD. As seen in de novo lymphoma, non-Hodgkin’s lymphoma (NHL) was the most common histological subtype (83.9%). Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma were the most represented NHL in patients with IBD (30% and 13% respectively). Two main differences were observed in comparison to de novo lymphoma: primary intestinal lymphoma (PIL) represented a large part of lymphoma in patients with IBD (22% to 75%) whereas mucosa-associated lymphoid tissue (MALT) lymphoma was under-represented. Epstein-Barr virus (EBV) positive status was observed in a large part of tumors (44 to 75%). Survival data of lymphoma in patients with IBD were similar to that of de novo lymphoma. Discussion This systematic review first highlights that PIL (especially DLBCL subtype) is significantly more frequent in patients with IBD and represents the most common entity. Conversely, MALT lymphoma is extremely rare in IBD population. However, the overall quality of the evidence is low. Further studies are required to better define lymphoma characteristics in patients with IBD.

show abstract

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients

Wei¹,

Xue²,

Ling³

et al. 2023

World J Gastrointest Surg

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Editorial: which inflammatory bowel disease patients should be screened for Epstein‐Barr virus infection? Authors’ reply

Abstract: Linked Content This article is linked to de Francisco et al and Hans and Scott papers. To view these articles visit https://doi.org/10.1111/apt.14933 and https://doi.org/10.1111/apt.14988.

Cited by 3 publications

References 6 publications

Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study

Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study

Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients

Contact Info

Product

Resources

About